FirstSpear TV

B-TEMIA Doubles its Commercialization and Manufacturing Capacities

Québec City, QC | October 25, 2016 – B-TEMIA Inc., the developer and manufacturer of the Dermoskeleton™ mobility assistive technology announces that it has recently opened its new head office in St-Augustin, Québec City. The new facility will enable the Company to double its commercialization and manufacturing capacities.

“In 2016, we decisively transitioned the Company towards the full commercialization of our Keeogo™ walking assistive device in Canada, while advancing the groundwork for its future introduction in the US market. It became clear that in order to service our customers more effectively and maintain our growth, we needed to move to a new location,“ said Stéphane Bédard, Founder and CEO of B-TEMIA. “Regrouping all our operations into one larger working space will significantly increase our capability to mature our industrial phase, improve our operational performance as well as upgrade our employees’ working environment ,” added Mr. Bedard.

B-TEMIA has now put in place all the necessary resources to accelerate its commercialization efforts and make its exclusive Keeogo™ device available throughout Canada. With over 20 employees, the Company has recently added key operational skills in sales, customer service, regulatory and clinical management to support its growth in the Canadian market and the completion of the US Food and Drug Administration (FDA) clearance process.


2 Responses to “B-TEMIA Doubles its Commercialization and Manufacturing Capacities”

  1. steve says:

    Give that keep clam patch a rest!

  2. defiant says:

    B-Temia, nice. Assume this means good news for the tip of the spear? 😉